ESR1 and breast carcinoma: In the current study, we showed that PHA inhibits the proliferation of three kinds of breast cancer cells: MCF7 (ER+, PR+/−, HER2−), SKBR3 (ER−, PR−, HER2+), and MDA-MB-231 (TNBC).